Zhang Li-Jun, Zhu Jian-Yong, Sun Meng-Yao, Song Ya-Nan, Rahman Khalid, Peng Cheng, Zhang Miao, Ye Yu-Mei, Zhang Hong
Central Laboratory, Seventh People's Hospital of Shanghai University of TCM, Shanghai 200137, China.
School of Pharmacy and Biomolecular Sciences, Faculty of Science, Liverpool John Moores University, Liverpool L3 3AF, England, UK.
J Ethnopharmacol. 2017 Aug 17;208:57-65. doi: 10.1016/j.jep.2017.06.034. Epub 2017 Jun 23.
Traditional Chinese Medicine (TCM) has become the focus of research for the treatment of chronic pelvic inflammatory disease (CPID) based on unique medical theory system. Man-Pen-Fang (MPF), a Chinese herbal compound, which is composed of Thlaspi arvense L. (Cruciferae), Gleditsia sinensis Lam. (Leguminosae), Smilax china L. (Liliaceae), Euonymus alatus (Thunb.) Sieb. (Celastraceae) and Vaccaria segetalis (Neck.) (Caryophyllaceae) MPF has been used for the treatment of CPID and exerted significant clinical curative effects. However, the corresponding active principles and anti-inflammatory mechanism of MPF are still unknown.
The objective of present study is to evaluate the effect of MPF on CPID in the chronic pelvic inflammation (CPI) rat model and elucidate its possible anti-inflammatory mechanism.
The CPI in rats was induced by administration with E. coli, Staphylococcus aureus and Beta-hemolytic streptococcus. MPF (8.112g/(kg d) (20 times of adult dosage), 4.056g/(kg d) (10 times of adult dosage) and 2.028g/(kg d) (5 times of adult dosage)) and Jingangteng Capsule 2g/(kg d) (20 times of adult dosage) were administered orally for 20 days. The serum levels of five inflammation-associated cytokines (IL-2, IL-6, IL-10, TNF-α and TGF-β) were determined by enzyme-linked immunoassay, and the mRNA expression levels of TGF-β, P53, Fas, FasL and MMP-2 in the uterus tissue were measured by quantitative RT-PCR. Furthermore, the expression of NF-κB p65 in uterus and ovary tissues was detected by immunohistochemistry assay and the pathological changes induced in the uterus and ovary tissues were observed by histology.
MPF caused a reduction in serum levels of IL-2, IL-6, IL-10, TNF-α and TGF-β. The expression of P53 mRNA, Fas/FasL mRNA and MMP-2 mRNA in the uterus tissue was significantly elevated after treating with MPF, in contrast the expression of TGF-β mRNA was decreased. Furthermore, the expression of NF-κB p65 in uterus and ovary tissue was inhibited after treating with MPF.
These results taken together suggest that MPF has a significant anti-CPID effect, probably due to inhibition of the inflammation reaction by the promotion, and the induction of the apoptosis of inflammatory cells and downregulation of the serum levels of inflammation cytokines.
基于独特的医学理论体系,传统中医(TCM)已成为慢性盆腔炎(CPID)治疗研究的焦点。蔓盆方(MPF)是一种由遏蓝菜(十字花科)、皂荚(豆科)、菝葜(百合科)、卫矛(卫矛科)和王不留行(石竹科)组成的中药复方。MPF已用于治疗CPID并发挥了显著的临床疗效。然而,MPF相应的活性成分和抗炎机制仍不清楚。
本研究的目的是评估MPF对慢性盆腔炎(CPI)大鼠模型中CPID的影响,并阐明其可能的抗炎机制。
通过给予大肠杆菌、金黄色葡萄球菌和β-溶血性链球菌诱导大鼠发生CPI。口服给予MPF(8.112g/(kg·d)(成人剂量的20倍)、4.056g/(kg·d)(成人剂量的10倍)和2.028g/(kg·d)(成人剂量的5倍))和金刚藤胶囊2g/(kg·d)(成人剂量的20倍),持续20天。采用酶联免疫吸附测定法测定血清中五种炎症相关细胞因子(IL-2、IL-6、IL-10、TNF-α和TGF-β)的水平,采用定量逆转录聚合酶链反应(RT-PCR)检测子宫组织中TGF-β、P53、Fas、FasL和MMP-2的mRNA表达水平。此外,通过免疫组织化学测定法检测子宫和卵巢组织中NF-κB p65的表达,并通过组织学观察子宫和卵巢组织中诱导的病理变化。
MPF使血清中IL-2、IL-6、IL-10、TNF-α和TGF-β水平降低。MPF处理后,子宫组织中P53 mRNA、Fas/FasL mRNA和MMP-2 mRNA的表达显著升高,相反,TGF-β mRNA的表达降低。此外,MPF处理后,子宫和卵巢组织中NF-κB p65的表达受到抑制。
综合这些结果表明,MPF具有显著的抗CPID作用,可能是由于通过促进炎症反应的抑制、诱导炎症细胞凋亡以及下调炎症细胞因子的血清水平来实现的。